company background image
SNTI

Senti Biosciences NasdaqGM:SNTI Stock Report

Last Price

US$2.41

Market Cap

US$105.7m

7D

6.6%

1Y

-75.9%

Updated

27 Nov, 2022

Data

Company Financials +
SNTI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

SNTI Stock Overview

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases.

Senti Biosciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Senti Biosciences
Historical stock prices
Current Share PriceUS$2.41
52 Week HighUS$10.35
52 Week LowUS$1.20
Beta0
1 Month Change4.33%
3 Month Change22.34%
1 Year Change-75.85%
3 Year Changen/a
5 Year Changen/a
Change since IPO-75.85%

Recent News & Updates

Will Senti Biosciences (NASDAQ:SNTI) Spend Its Cash Wisely?

Sep 27
Will Senti Biosciences (NASDAQ:SNTI) Spend Its Cash Wisely?

Senti Biosciences initiated at buy at Chardan on gene circuit synthetic biology platform

Sep 22

Senti Biosciences GAAP EPS of -$0.86, revenue of $1.36M

Aug 16

Recent updates

Will Senti Biosciences (NASDAQ:SNTI) Spend Its Cash Wisely?

Sep 27
Will Senti Biosciences (NASDAQ:SNTI) Spend Its Cash Wisely?

Is Senti Biosciences (NASDAQ:SNTI) In A Good Position To Invest In Growth?

Jun 13
Is Senti Biosciences (NASDAQ:SNTI) In A Good Position To Invest In Growth?

Shareholder Returns

SNTIUS BiotechsUS Market
7D6.6%0.4%1.3%
1Y-75.9%-14.4%-18.5%

Return vs Industry: SNTI underperformed the US Biotechs industry which returned -14.4% over the past year.

Return vs Market: SNTI underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is SNTI's price volatile compared to industry and market?
SNTI volatility
SNTI Average Weekly Movement39.0%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: SNTI is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 39% a week.

Volatility Over Time: SNTI's weekly volatility has increased from 24% to 39% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201689Tim Luhttps://www.sentibio.com

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia cells, while sparing the healthy bone marrow; and SENTI-301, a multi-armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma.

Senti Biosciences, Inc. Fundamentals Summary

How do Senti Biosciences's earnings and revenue compare to its market cap?
SNTI fundamental statistics
Market CapUS$105.70m
Earnings (TTM)-US$50.90m
Revenue (TTM)US$5.02m

21.1x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SNTI income statement (TTM)
RevenueUS$5.02m
Cost of RevenueUS$21.96m
Gross Profit-US$16.94m
Other ExpensesUS$33.97m
Earnings-US$50.90m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.16
Gross Margin-337.39%
Net Profit Margin-1,014.02%
Debt/Equity Ratio0%

How did SNTI perform over the long term?

See historical performance and comparison